about
Persistent depressive symptoms lower aspirin adherence after acute coronary syndromesCourse of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring studyLetter by Kronish et al regarding article, "Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance"Concepts of care for people with dementia.Primary prevention in general practice - views of German general practitioners: a mixed-methods study.Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot studyEnhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.Is depression after an acute coronary syndrome simply a marker of known prognostic factors for mortality?Berlin evaluates school tobacco prevention - BEST prevention: study design and methodology.Aspirin adherence, aspirin dosage, and C-reactive protein in the first 3 months after acute coronary syndrome.Long-term outcomes of enhanced depression treatment in patients with acute coronary syndromes.Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome.Directionality of the relationship between depressive symptom dimensions and C-reactive protein in patients with acute coronary syndromesPosttraumatic stress due to an acute coronary syndrome increases risk of 42-month major adverse cardiac events and all-cause mortalityVitamin D status among adults in Germany--results from the German Health Interview and Examination Survey for Adults (DEGS1)Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes.Psychological theories of depression: potential application for the prevention of acute coronary syndrome recurrence.Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.Psychosocial vulnerabilities to depression after acute coronary syndrome: the pivotal role of rumination in predicting and maintaining depressionDefinitions and distinctions among depressive syndromes and symptoms: implications for a better understanding of the depression-cardiovascular disease association.Treating persistent depressive symptoms in post-ACS patients: the project COPES phase-I randomized controlled trial.Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report.Incident and recurrent major depressive disorder and coronary artery disease severity in acute coronary syndrome patients.The effect of enhanced depression care on adherence to risk-reducing behaviors after acute coronary syndromes: findings from the COPES trial.The effect of enhanced depression care on anxiety symptoms in acute coronary syndrome patients: findings from the COPES trialSerotonin reuptake inhibitor use, depression, and long-term outcomes after an acute coronary syndrome: a prospective cohort study.The psychosocial context impacts medication adherence after acute coronary syndrome.Computed tomography versus invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial.Psychometric properties of the Perceived Stress Scale in a sample of German dementia patients and their caregivers.Association between vitamin D and depressive symptoms varies by season: Results from the German Health Interview and Examination Survey for Adults (DEGS1).Depressed mood and its functional correlates in institutionalized schizophrenia patients.Long-term effect of a low-intensity smoking intervention embedded in an adherence program for patients with hypercholesterolemia: Randomized controlled trial.Aspirin adherence, depression and one-year prognosis after acute coronary syndrome.Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndromeTreatment preferences among depressed patients after acute coronary syndrome: the COPES observational cohort.Gene-environment interactions and depression.Effect of a Website That Presents Patients' Experiences on Self-Efficacy and Patient Competence of Colorectal Cancer Patients: Web-Based Randomized Controlled Trial.Barriers to routine risk-score use for healthy primary care patients: survey and qualitative study.Physician specialty and long-term survival after myocardial infarction - A study including all German statutory health insured patients.Long-term effectiveness of a combined student-parent and a student-only smoking prevention intervention among 7th grade school children in Berlin, Germany.
P50
Q28201292-9F870BF6-6D31-4A48-83A4-869264B68806Q28212320-A91A8592-807B-403F-AE5D-248B78508415Q28218073-0DE88C20-4773-48DF-8314-6DB6D6E2B6B2Q30399293-734CD078-0600-4397-95D3-297C0DDD5C77Q33714756-35A07DAC-7F76-4E8E-BF1C-1EC8ECB9053FQ33832945-B0979181-6765-4FBC-9935-2B7D2A9FEA7CQ33900047-0ADF0F78-35D5-4960-AD26-67FAB6AD4C47Q34011825-50C9FEEA-EDA8-4E1A-839B-7BE11AEF9FF5Q34136006-7A991DC8-82AE-4FA4-A0FF-A2D58F881AAEQ34257748-D3165528-D898-464C-8628-1C0E5C2B37C3Q34345168-D3CC7B1E-702B-4A76-B93F-805A1B51C3A4Q34678771-13FBA99B-6C27-4416-A762-63F4D12381E2Q35032401-C9A8AB29-B140-40E2-A615-80FDD19C73CBQ35534251-55816B84-5BB2-4447-B2C5-0ECB2978208FQ35688496-B154C61A-10B7-4AE9-81E8-28DA791CBB16Q35696271-EC1C532E-714F-460C-9A35-D247A78FA4D2Q35708633-D417D24D-8FD7-4C56-B8DB-548AAD501A34Q35851255-5E289C8F-3912-4D1D-8238-CCA29AE232CFQ36158906-B7D3BA7C-F254-4E8B-844B-1D0019ECC8CCQ36161785-B49B4BA6-9619-4767-86B0-284ACFAE3C54Q36563063-494A3F65-C45E-4A02-B314-C2D43DA7A105Q36608948-38A7676B-062C-48D1-BEB7-4F0783E63C40Q36681325-13FFB13B-C733-4747-BF86-EBF99702314EQ36714056-E3E1D0B3-62B1-4C77-968E-ACD780C01BBFQ36806788-A09073D3-CDB2-4202-921E-49CF0D02209EQ37032247-19495870-D24E-4E4C-8456-54DBB9EC002FQ37666296-07B9E7AC-FBC7-4D9A-AFD6-E3878C8B82F6Q38375702-F9D7CF94-31BD-473E-A146-E3117043E8B3Q38665323-35718340-595D-4CB1-8BC7-A835821F5BF5Q39657250-6DFB6BBB-510F-4853-A1E7-737434A42B3AQ40422590-47F538D8-FDAD-413F-BBAD-487A9F82D771Q41688356-7208B729-5E4C-4E40-8710-0768A708D3ECQ42789086-D923C769-77BC-4A98-B786-74A601E035DFQ42830502-5F4DE658-6019-497A-B308-2EB9920DA958Q42975082-AD55BAC2-B399-4332-BA35-086E284027B5Q43146309-3DD54FEF-1E97-4C10-B8ED-19FCB69C6B7AQ46369043-B0C65DC7-E173-4FEB-B181-1AFAB191E8A5Q46421214-4E66C9D1-EB58-409B-B63A-5EAF3A0AE9A6Q47674913-EC3C2588-33AC-4B07-A72A-67906D260A11Q47734915-09FB942F-BB27-491C-A172-298CCD8BE7F7
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nina Rieckmann
@ast
Nina Rieckmann
@en
Nina Rieckmann
@es
Nina Rieckmann
@nl
Nina Rieckmann
@sl
type
label
Nina Rieckmann
@ast
Nina Rieckmann
@en
Nina Rieckmann
@es
Nina Rieckmann
@nl
Nina Rieckmann
@sl
prefLabel
Nina Rieckmann
@ast
Nina Rieckmann
@en
Nina Rieckmann
@es
Nina Rieckmann
@nl
Nina Rieckmann
@sl
P106
P21
P31
P496
0000-0002-6870-451X